Key committee meets Thursday to consider FDA authorization for Pfizer/BioNTech Covid-19 vaccine

There's not much suspense going into Thursday's meeting of the US Food and Drug Administration's vaccine advisers, who are discussing emergency use authoriza...

Posted: Dec 10, 2020 9:48 AM
Updated: Dec 10, 2020 6:58 PM

There's not much suspense going into Thursday's meeting of the US Food and Drug Administration's vaccine advisers, who are discussing emergency use authorization for Pfizer and BioNTech's coronavirus vaccine.

The EUA is widely expected and has been telegraphed with unusual frankness from the top of the FDA on down.

'Our team has done their initial analysis, and we do feel that preliminarily that the success criteria have been met,' FDA Commissioner Dr. Stephen Hahn told CNN Tuesday.

But the FDA has promised to listen to the advice of its Vaccines and Related Biological Products Advisory Committee, made up of independent vaccine experts, infectious disease specialists, industry representatives and a consumer representative -- 17 regular members and 13 temporary voting members. The meeting begins at 9 a.m. Thursday, and a committee vote could come in the afternoon.

The only real questions will be about whether the advisers recommend restrictions to the EUA -- perhaps leaving children off the lIst for now, for example. They'll also discuss how to conduct the post-EUA safety surveillance and whether to offer the shot to clinical trial volunteers who got placebo doses.

Unprecedented speed for vaccines

The US federal government is supporting the development of seven coronavirus vaccines -- four of them in large Phase 3 clinical trials. Two, made by Pfizer and Moderna, have now applied for EUAs.

All have been developed with unprecedented speed. The virus known as SARS-CoV-2 was only identified in January but just weeks after it was isolated, the Chinese government shared its genetic sequence and that was enough to get work started on vaccines.

Companies, academic researchers and the federal government had been working to develop so-called platforms that could be used to quickly turn around new vaccines. The first two to the finish line, Pfizer's and Moderna's, use a plug-and-play technology involving genetic material known as messenger RNA.

The approach had already been tried out against infectious diseases such as Zika and against cancer as well, so researchers were confident it was safe. It is also far faster than old-fashioned vaccine development techniques such as, for instance, influenza vaccines, which require samples of the actual virus which must be grown in specially chosen chicken eggs, purified and made into a vaccine -- an uncertain and slow process.

The mRNA vaccines need just a short stretch of genetic code and employ the human body itself to make its own vaccine. Tests in tens of thousands of volunteers starting in the summer showed it elicited an immune response and appeared to do so safely.

'We've shortened vaccine timelines here without compromising vaccine safety and efficacy,' Dr. Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research, which approves vaccines, told an American Medical Association webinar.

'The fact that we have so many cases of Covid-19 right now, it's so unfortunate for us as a country. The only upside to it is when you are doing a clinical trial with an endpoint that's a clinical infectious disease endpoint, it's been easy to get to those endpoints because there's just so many cases,' Marks added.

'By August to October of this year it became clearer to us that the first vaccines that came through would indeed likely be granted emergency use authorization because of the incredibly pressing nature of this crisis.'

Getting 'down and dirty' with vaccine data

Pfizer's vaccine does have what researchers have described as breathtaking efficacy. The company released its first data in media releases, but turned over tens of thousands of pages of it data to the FDA for closer study.

Drug companies usually write up summaries of their findings for regulators, but the FDA also asks for all of the primary source material -- the charts, even each volunteer's individual record. Marks said staffers have studied that.

'We are the ones that actually don't just look at the companies' tables. We actually get down and dirty and we look at the actual adverse event reports, the bad spelling errors that are made by physicians sometimes, et cetera,' Marks said.

'They had 95% effectiveness across a wide range of individuals,' he told the AMA.

The FDA published its summary and Pfizer's summary on the Vaccines and Related Biological Products Advisory Committee website Tuesday, and the 95% efficacy claims hold up.

'Vaccine efficacy against confirmed COVID-19 occurring at least 7 days after Dose 2 was 94.6%, with 9 and 169 cases in the BNT162b2 (the vaccine's experimental name) and placebo groups respectively,' the FDA review document reads.

In other words, nine people who got the vaccine developed coronavirus infections with symptoms after the second shot, while 169 people who got placebo shots became infected.

The committee will run through all this data, but members will have read it all before Thursday's meeting, which will be livestreamed on YouTube, Twitter and the FDA's website.

How the meeting unfolds

Staff at the FDA's Office of Vaccines Research and Review will run down the FDA's study of Pfizer's data. Dr. Nancy Messonnier, who heads the US Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases, will review the CDC's plans for safety monitoring and other CDC officials will update on the pandemic itself and plans for distributing the vaccine.

Stanford University's Dr. Steven Goodman will talk about what it means for clinical trials going forward if a vaccine is approved. He'll address the question of asking people to forgo getting a vaccine known to be protective in order to test an unproven one.

Other possible questions are whether to include pregnant women and children in an EUA.

'At this point I would say, we may not have the data we need to actually be able to advise pregnant women, and we may need additional study,' Hahn said.

The committee members will almost certainly discuss allergy warnings out of Britain's vaccination campaign, as well.

And the National Vaccine Advisory Committee asked the FDA to leave children out of an EUA.

'The NVAC warns against issuing an Emergency Use Authorization (EUA) for COVID-19 vaccines in children, considering that children typically experience generally mild disease, except for multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition that causes inflammation and various symptoms such as abdominal pain, vomiting, diarrhea, neck pain, rash, tiredness, and bloodshot eyes,' the group said last week.

Pfizer will also present its data.

Then the committee votes whether to recommend authorization.

But that doesn't mean the vaccine will be authorized immediately. The decision comes from the FDA, which typically follows the advisory committee's recommendation.

'One question that will come up is how fast will we see a vaccine authorized after that,' FDA's Marks told the AMA.

'It will depend on the discussion at the advisory committee but we are hoping that within about a week afterwards we will see an authorization if everything goes well for each of those,' Marks said.

It could come even sooner. In anticipation of an EUA, the CDC's Advisory Committee on Immunization Practices has scheduled emergency meetings for Friday and Sunday. This committee -- which is separate from FDA's advisory committee -- will recommend whether the CDC should offer the vaccine to the American public.

Once the CDC accepts that recommendation, healthcare workers may start giving people their fisrt doses of Pfizer vaccine.

The VRPBAC is scheduled to do it all over again next week, with a meeting December 17 to discuss Moderna's EUA application.

Terre Haute
Partly Cloudy
72° wxIcon
Hi: 73° Lo: 44°
Feels Like: 72°
Robinson
Partly Cloudy
69° wxIcon
Hi: 74° Lo: 45°
Feels Like: 69°
Indianapolis
Partly Cloudy
70° wxIcon
Hi: 73° Lo: 45°
Feels Like: 70°
Rockville
Partly Cloudy
69° wxIcon
Hi: 70° Lo: 44°
Feels Like: 69°
Casey
Mostly Cloudy
67° wxIcon
Hi: 69° Lo: 47°
Feels Like: 67°
Brazil
Partly Cloudy
72° wxIcon
Hi: 71° Lo: 44°
Feels Like: 72°
Marshall
Partly Cloudy
72° wxIcon
Hi: 71° Lo: 42°
Feels Like: 72°
Clouds move in today with showers possible this evening.
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1363409

Reported Deaths: 24725
CountyCasesDeaths
Cook54578510114
DuPage906281281
Will75577990
Lake67248988
Kane58414774
Winnebago33247475
Madison30525520
McHenry28604288
St. Clair27862514
Peoria23136315
Champaign20649145
Sangamon18762234
McLean18167179
Tazewell16959288
Rock Island14994317
Kankakee14193210
Kendall1306094
LaSalle12553243
Macon10762199
DeKalb9874119
Vermilion9653132
Adams8466123
Williamson7433130
Whiteside7165172
Boone670773
Ogle611481
Grundy589375
Clinton576090
Coles568795
Knox5565145
Jackson502764
Henry498167
Livingston482585
Stephenson475983
Woodford475176
Effingham472972
Macoupin470282
Marion4472115
Franklin445075
Monroe435793
Jefferson4296120
Lee416952
Randolph413184
Fulton392756
Morgan390382
Logan388058
Bureau372082
Montgomery372074
Christian366773
Perry317560
Fayette317455
Iroquois302266
McDonough285647
Jersey268950
Douglas258835
Saline256454
Lawrence240525
Shelby229837
Union226040
Crawford212026
Bond205024
Cass199225
Jo Daviess181524
Clark179833
Warren179846
Pike179152
Ford178647
Wayne177553
Hancock176032
Carroll175436
Richland175040
Edgar170440
White169726
Washington164525
Moultrie161028
De Witt151324
Mason151045
Piatt149814
Clay148143
Mercer147033
Johnson144415
Greene143733
Wabash134512
Massac134340
Cumberland129019
Menard123612
Jasper115018
Marshall107318
Hamilton83315
Schuyler7587
Brown7066
Pulaski6877
Stark63823
Edwards57112
Henderson52514
Calhoun5182
Putnam4823
Scott4791
Alexander46811
Gallatin4584
Hardin38612
Pope3224
Out of IL40
Unassigned02356

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 733591

Reported Deaths: 13466
CountyCasesDeaths
Marion1003871748
Lake54020975
Allen40829679
St. Joseph35898552
Hamilton35735408
Elkhart28745442
Tippecanoe22432219
Vanderburgh22342397
Porter18871310
Johnson18028381
Hendricks17283315
Clark13015191
Madison12725339
Vigo12482248
LaPorte12011214
Monroe11928170
Delaware10726187
Howard9959218
Kosciusko9451117
Hancock8325142
Bartholomew8085156
Warrick7792155
Floyd7677178
Grant7080174
Wayne7064199
Boone6722101
Morgan6596139
Dubois6162117
Marshall6083112
Cass5839105
Dearborn582178
Henry5767104
Noble563684
Jackson502773
Shelby493696
Lawrence4571120
Harrison436372
Gibson436292
DeKalb429685
Clinton428153
Montgomery425389
Whitley397439
Huntington393380
Steuben390057
Miami382668
Knox372690
Jasper370148
Putnam362360
Wabash354980
Adams341955
Ripley340270
Jefferson331581
White315654
Daviess298299
Wells291981
Decatur285692
Fayette281662
Greene280085
Posey271933
LaGrange268370
Scott267254
Clay260647
Washington241832
Randolph241481
Spencer232631
Jennings230649
Starke217854
Fountain213246
Sullivan212142
Owen202156
Jay196730
Fulton195640
Carroll189620
Orange184154
Perry184037
Rush173725
Vermillion169743
Franklin168435
Tipton163045
Parke146616
Blackford135132
Pike135134
Pulaski117145
Newton108334
Brown102641
Crawford101315
Benton99014
Martin89515
Warren82415
Switzerland7938
Union71110
Ohio57111
Unassigned0417